21.69
-0.14
(-0.64%)
Real-time:
3:07PM EDT
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 21.39 - 21.75 |
| 52 week | 11.80 - 24.93 |
| Open | 21.64 |
| Vol / Avg. | 452,485.00/417,314.00 |
| Mkt cap | 837.26M |
| P/E | 59.30 |
| Div/yield | - |
| EPS | 0.37 |
| Shares | 38.60M |
| Beta | 1.27 |
| Inst. own | 107% |
Events
Jul 29, 2013
Q1 2014 Abiomed, Inc. Earnings Release
May 29, 2013
Abiomed, Inc. at Deutsche Bank 38th Annual dbAccess Health Care Conference
- 2:50PM EDT -
May 22, 2013
Abiomed, Inc. at UBS Global Healthcare Conference
May 15, 2013
Abiomed, Inc. at Bank of America Merrill Lynch Health Care Conference
May 14, 2013
Q4 2013 Abiomed, Inc. Earnings Release
May 7, 2013
Abiomed, Inc. at Bank of America Merrill Lynch Smid Cap Conference
May 2, 2013
Q4 2013 Abiomed, Inc. Earnings Conference Call
Mar 14, 2013
Abiomed, Inc. at Barclays Healthcare Conference
Mar 6, 2013
Abiomed, Inc. at Cowen Health Care Conference
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2013 | |
| Net profit margin | 8.57% | 9.50% |
| Operating margin | 9.46% | 10.46% |
| EBITD margin | - | 10.53% |
| Return on average assets | 8.96% | 9.27% |
| Return on average equity | 10.99% | 11.40% |
| Employees | 397 | - |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
ABIOMED, Inc. develops temporary and permanent cardiac support systems. The Company develops, manufactures and markets medical technologies designed to assist or replace the pumping function of the failing heart. It focuses on the development of two temporary support systems, the bi-ventricular support system (BVS) and the intra-arterial cardiac support system (ICs). The Company sells its products through direct sales representatives and clinical support personnel in the United States, Germany, France, the United Kingdom, and Ireland; and internationally.
Officers and directors
| Michael R. Minogue | Chairman of the Board, President, Chief Executive Officer | |
| Robert L. Bowen | Chief Financial Officer, Vice President, Treasurer | |
| David M. Weber | Chief Operating Officer | |
| William J. Bolt | Senior Vice President - Global Product Operations | |
| Michael G. Howley | Vice President, General Manager - Global Sales and Marketing | |
| Andrew Greenfield | Vice President - Healthcare Solutions | |
| Dorothy E. Puhy | Lead Independent Director | |
| W. Gerald Austen M.D. | Independent Director | |
| Louis E. Lataif | Independent Director | |
| Martin P. Sutter | Independent Director |